Here, we sought to better understand a pathway through which the EML4–ALK V3 fusion variant, which promotes rapid metastatic spread in NSCLC, causes cells to adopt a mesenchymal-like morphology typical of migratory and invasive tumor cells (10, 16). The gene discussed is ALK; the disease is non-small cell lung carcinoma.